BIO-Europe Spring: Interview with Matthew Durdy, Cell Therapy Catapult

April 8, 2014
Matthew Durdy, Chief Business Officer at Cell Therapy Catapult, discusses the role of cell-based therapies in the next generation of healthcare, and strategies companies can use to take their innovative ideas through to commercialization. For more information on BIO-Europe Spring, visit our webpage: http://www.ebdgroup.com/bes/index.php Please view the rest of the video at http://www.partnering360.com/insight/showroom/id/489
Previous Video
BIO-Europe Spring 2014: Interview with Mike Crowley, Genentech
BIO-Europe Spring 2014: Interview with Mike Crowley, Genentech

Genentech is known for its oncology franchise, but the company also has a significant footprint in immunolo...

Next Video
BIO-Europe Spring 2014: Interview with Sigal Weisswasser, The T.B.N. Group
BIO-Europe Spring 2014: Interview with Sigal Weisswasser, The T.B.N. Group

Sigal Weißwasser is the President of Technology Business Networks—The T.B.N. Group—a leading player in toda...